Literature DB >> 21480224

An RNAi screen identifies USP2 as a factor required for TNF-α-induced NF-κB signaling.

Marie Metzig1, Dorothee Nickles, Christina Falschlehner, Judith Lehmann-Koch, Beate K Straub, Wilfried Roth, Michael Boutros.   

Abstract

Tumor necrosis factor α (TNF-α) signaling pathways play important roles during tumorigenesis and inflammation. Ubiquitin-dependent processes are central to the regulation of TNF-α and nuclear factor κB (NF-κB) signaling. We performed a targeted siRNA screen for ubiquitin-specific proteases (USPs) and identified USP2 as a modulator of TNF-α-induced NF-κB signaling. We showed that USP2 is required for the phosphorylation of IκB, nuclear translocation of NF-κB and expression of NF-κB-dependent target genes and IL-8 secretion. Our study also provides evidence for isoform-specific functions of USP2. The immunohistochemical analysis of breast carcinomas revealed that USP2 expression is frequently downregulated. Together, our results implicate USP2 as a novel positive regulator of TNF-α-induced NF-κB signaling and show that its expression is altered in tumor cells.
Copyright © 2011 UICC.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21480224     DOI: 10.1002/ijc.26124

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  29 in total

1.  USP2a protein deubiquitinates and stabilizes the circadian protein CRY1 in response to inflammatory signals.

Authors:  Xin Tong; Katie Buelow; Anirvan Guha; Rebecca Rausch; Lei Yin
Journal:  J Biol Chem       Date:  2012-06-05       Impact factor: 5.157

2.  Transcriptome signature of resistance exercise adaptations: mixed muscle and fiber type specific profiles in young and old adults.

Authors:  Ulrika Raue; Todd A Trappe; Shawn T Estrem; Hui-Rong Qian; Leah M Helvering; Rosamund C Smith; Scott Trappe
Journal:  J Appl Physiol (1985)       Date:  2012-02-02

Review 3.  The Emerging Role of Non-traditional Ubiquitination in Oncogenic Pathways.

Authors:  Lisa Dwane; William M Gallagher; Tríona Ní Chonghaile; Darran P O'Connor
Journal:  J Biol Chem       Date:  2017-02-01       Impact factor: 5.157

4.  A genome-wide RNA interference screen identifies caspase 4 as a factor required for tumor necrosis factor alpha signaling.

Authors:  Dorothee Nickles; Christina Falschlehner; Marie Metzig; Michael Boutros
Journal:  Mol Cell Biol       Date:  2012-06-25       Impact factor: 4.272

Review 5.  Regulation of NF-κB by deubiquitinases.

Authors:  Edward W Harhaj; Vishva M Dixit
Journal:  Immunol Rev       Date:  2012-03       Impact factor: 12.988

6.  The ubiquitin-specific protease USP2a prevents endocytosis-mediated EGFR degradation.

Authors:  Z Liu; S M Zanata; J Kim; M A Peterson; D Di Vizio; L R Chirieac; S Pyne; M Agostini; M R Freeman; M Loda
Journal:  Oncogene       Date:  2012-06-18       Impact factor: 9.867

7.  Epigenetic changes associated with inflammation in breast cancer patients treated with chemotherapy.

Authors:  Alicia K Smith; Karen N Conneely; Thaddeus W W Pace; Donna Mister; Jennifer C Felger; Varun Kilaru; Mary J Akel; Paula M Vertino; Andrew H Miller; Mylin A Torres
Journal:  Brain Behav Immun       Date:  2014-02-28       Impact factor: 7.217

8.  A genome-wide siRNA screen reveals positive and negative regulators of the NOD2 and NF-κB signaling pathways.

Authors:  Neil Warner; Aaron Burberry; Luigi Franchi; Yun-Gi Kim; Christine McDonald; Maureen A Sartor; Gabriel Núñez
Journal:  Sci Signal       Date:  2013-01-15       Impact factor: 8.192

9.  USP2a positively regulates TCR-induced NF-κB activation by bridging MALT1-TRAF6.

Authors:  Yi Li; Xiao He; Shuai Wang; Hong-Bing Shu; Yu Liu
Journal:  Protein Cell       Date:  2012-12-20       Impact factor: 14.870

10.  Macrophage ubiquitin-specific protease 2 contributes to motility, hyperactivation, capacitation, and in vitro fertilization activity of mouse sperm.

Authors:  Mayuko Hashimoto; Shunsuke Kimura; Chihiro Kanno; Yojiro Yanagawa; Takafumi Watanabe; Jun Okabe; Eiki Takahashi; Masashi Nagano; Hiroshi Kitamura
Journal:  Cell Mol Life Sci       Date:  2020-10-26       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.